Global State of Information Security 2016

For pharmaceuticals and life sciences organisations, an enhanced cybersecurity programme is a priority amid rapidly rising risks to employee and patient data, intellectual property, clinical trials results and information generated by health-monitoring devices. To address these threats and improve cybersecurity, many are implementing cloud-based cybersecurity and granular access control. They are also addressing the human aspects of security by hiring a Chief Information Security Officer (CISO) and elevating Board involvement in cybersecurity.

Global State of Information Security 2016

Contact us

Ron Admiraal

Partner, PwC Netherlands

Tel: +31 (0)88 792 15 46

Bram van Tiel

Partner Cybersecurity & Dataprivacy, PwC Netherlands

Tel: +31 (0)88 792 53 88

Follow us